2010
DOI: 10.1111/j.1440-1681.2010.05438.x
|View full text |Cite
|
Sign up to set email alerts
|

Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling

Abstract: 1. Hyperhomocysteinaemia (HHcy) is associated with endothelial dysfunction and has been recognized as a risk factor of cardiovascular disease. The present study aimed to investigate the effect of homocysteine (Hcy) on endothelial function in vivo and in vitro, and the underlying signalling pathways. 2. The HHcy animal model was established by intragastric administration with l-methionine in rats. Plasma Hcy and nitric oxide (NO) concentration were measured by fluorescence immunoassay or nitrate reductase metho… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
13
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(14 citation statements)
references
References 35 publications
1
13
0
Order By: Relevance
“…Inhibition of AKT activation by dominant negative AKT mutants prevents enhanced NO synthesis mediated by eNOS [33]. Other studies indicated the role of AKT in Hcy-induced cell cycle G1 arrest [34] and impaired endothelial function [35]. Given these background, we hypothesized that Se may protect the function of endothelial cells in an AKT-dependent manner.…”
Section: Discussionmentioning
confidence: 99%
“…Inhibition of AKT activation by dominant negative AKT mutants prevents enhanced NO synthesis mediated by eNOS [33]. Other studies indicated the role of AKT in Hcy-induced cell cycle G1 arrest [34] and impaired endothelial function [35]. Given these background, we hypothesized that Se may protect the function of endothelial cells in an AKT-dependent manner.…”
Section: Discussionmentioning
confidence: 99%
“…Hyperhomocysteinemia (HHcy) is associated with CVD and PAD [137,[142][143][144] and a deficiency of folic acid has been previously linked to endothelial dysfunction, atherosclerosis, stroke and CLI [145]. HHcy is associated with decreased levels of global genome-wide CpG methylation and promoter-specific gene methylation, promoting altered expression levels of a number of genes relevant to vascular damage [125,[146][147][148][149]. Furthermore, HHcy also suppresses angiogenesis, promotes SMC proliferation, promotes dyslipidaemia, stimulates vascular oxidative stress, and leads to impairment of EC regeneration and function [125,148].…”
Section: Epigenetic Effects Of Risk Factors For Cvd and Padmentioning
confidence: 99%
“…HHcy is associated with decreased levels of global genome-wide CpG methylation and promoter-specific gene methylation, promoting altered expression levels of a number of genes relevant to vascular damage [125,[146][147][148][149]. Furthermore, HHcy also suppresses angiogenesis, promotes SMC proliferation, promotes dyslipidaemia, stimulates vascular oxidative stress, and leads to impairment of EC regeneration and function [125,148]. Advanced age is a major risk factor for CVD and PAD and aging is known to cause altered gene expression patterns due to epigenetic changes [150,151].…”
Section: Epigenetic Effects Of Risk Factors For Cvd and Padmentioning
confidence: 99%
“…Recently, evidence has suggested that PI3-K/Akt signaling pathway plays an important role in osteoclast differentiation and osteoclastogenesis [37][38][39]. Likewise, it is generally accepted that Hcy-induced activation of macrophages and endothelial cells is involved in the PI3K/Akt signaling pathway, ERK and oxidative stress [40][41][42].…”
Section: Discussionmentioning
confidence: 99%